TCRX NASDAQ
TScan Therapeutics, Inc.
1W: -5.7%
1M: -15.9%
3M: -69.5%
YTD: -68.6%
1Y: -84.7%
3Y: -88.0%
5Y: -95.9%
$0.32
+0.00 (+0.94%)
Weekly Expected Move ±11.0%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
ESG Scores — TCRX
Company vs Sector Average
Historical ESG Trend
View All ESG Filings (17)
| Date | Form | Environmental | Social | Governance | ESG Score | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | 10-Q | 54.5 | 58.3 | 57.0 | 56.5 | SEC ↗ |
| 2026-03-31 | 10-Q | 53.8 | 57.1 | 57.1 | 56.0 | SEC ↗ |
| 2025-12-31 | 10-K | 55.0 | 61.5 | 58.9 | 58.5 | SEC ↗ |
| 2025-09-30 | 10-Q | 53.7 | 58.0 | 57.6 | 56.4 | SEC ↗ |
| 2025-06-30 | 10-Q | 53.9 | 58.0 | 58.0 | 56.6 | SEC ↗ |
| 2025-03-31 | 10-Q | 53.6 | 57.6 | 57.3 | 56.1 | SEC ↗ |
| 2024-12-31 | 10-K | 53.8 | 62.0 | 60.0 | 58.6 | SEC ↗ |
| 2024-06-30 | 10-Q | 54.7 | 58.1 | 58.4 | 57.1 | SEC ↗ |
| 2024-03-31 | 10-Q | 55.3 | 58.0 | 58.4 | 57.2 | SEC ↗ |
| 2023-12-31 | 10-K | 53.4 | 62.0 | 59.3 | 58.2 | SEC ↗ |
| 2023-09-30 | 10-Q | 55.4 | 61.4 | 59.8 | 58.8 | SEC ↗ |
| 2023-06-30 | 10-Q | 55.9 | 61.6 | 60.4 | 59.3 | SEC ↗ |
| 2023-03-31 | 10-Q | 55.4 | 61.6 | 59.5 | 58.8 | SEC ↗ |
| 2022-12-31 | 10-K | 53.1 | 63.8 | 60.8 | 59.2 | SEC ↗ |
| 2022-09-30 | 10-Q | 55.7 | 61.1 | 60.3 | 59.0 | SEC ↗ |
| 2022-06-30 | 10-Q | 56.0 | 60.9 | 60.2 | 59.0 | SEC ↗ |
| 2021-12-31 | 10-K | 54.6 | 62.8 | 61.8 | 59.7 | SEC ↗ |